Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005868 | cytoplasmic dynein complex | 4 | 1 |
GO:0005875 | microtubule associated complex | 2 | 1 |
GO:0005930 | axoneme | 2 | 1 |
GO:0030286 | dynein complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A4H9I4
Term | Name | Level | Count |
---|---|---|---|
GO:0007017 | microtubule-based process | 2 | 1 |
GO:0007018 | microtubule-based movement | 3 | 1 |
GO:0009987 | cellular process | 1 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0045505 | dynein intermediate chain binding | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 47 | 51 | PF00656 | 0.569 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.331 |
CLV_PCSK_KEX2_1 | 42 | 44 | PF00082 | 0.635 |
CLV_PCSK_PC1ET2_1 | 42 | 44 | PF00082 | 0.558 |
CLV_PCSK_SKI1_1 | 201 | 205 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 42 | 46 | PF00082 | 0.729 |
DOC_CYCLIN_yCln2_LP_2 | 199 | 205 | PF00134 | 0.416 |
DOC_MAPK_gen_1 | 213 | 221 | PF00069 | 0.324 |
DOC_PP2B_LxvP_1 | 142 | 145 | PF13499 | 0.529 |
DOC_USP7_MATH_1 | 130 | 134 | PF00917 | 0.539 |
DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.588 |
DOC_USP7_MATH_1 | 81 | 85 | PF00917 | 0.700 |
DOC_WW_Pin1_4 | 120 | 125 | PF00397 | 0.445 |
DOC_WW_Pin1_4 | 157 | 162 | PF00397 | 0.597 |
DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.576 |
LIG_14-3-3_CanoR_1 | 108 | 118 | PF00244 | 0.520 |
LIG_14-3-3_CanoR_1 | 157 | 161 | PF00244 | 0.589 |
LIG_14-3-3_CanoR_1 | 32 | 40 | PF00244 | 0.625 |
LIG_14-3-3_CanoR_1 | 43 | 52 | PF00244 | 0.618 |
LIG_Actin_WH2_2 | 17 | 34 | PF00022 | 0.542 |
LIG_APCC_ABBA_1 | 122 | 127 | PF00400 | 0.473 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.650 |
LIG_BIR_III_4 | 129 | 133 | PF00653 | 0.507 |
LIG_BRCT_BRCA1_1 | 122 | 126 | PF00533 | 0.460 |
LIG_EH1_1 | 204 | 212 | PF00400 | 0.323 |
LIG_FHA_1 | 158 | 164 | PF00498 | 0.567 |
LIG_FHA_1 | 26 | 32 | PF00498 | 0.611 |
LIG_FHA_2 | 43 | 49 | PF00498 | 0.566 |
LIG_LIR_Apic_2 | 223 | 229 | PF02991 | 0.416 |
LIG_LIR_Gen_1 | 182 | 192 | PF02991 | 0.416 |
LIG_LIR_Gen_1 | 249 | 255 | PF02991 | 0.368 |
LIG_LIR_Nem_3 | 182 | 187 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 249 | 255 | PF02991 | 0.368 |
LIG_MLH1_MIPbox_1 | 122 | 126 | PF16413 | 0.460 |
LIG_SH2_CRK | 245 | 249 | PF00017 | 0.297 |
LIG_SH2_NCK_1 | 245 | 249 | PF00017 | 0.473 |
LIG_SH2_STAT5 | 125 | 128 | PF00017 | 0.523 |
LIG_SH3_3 | 145 | 151 | PF00018 | 0.685 |
LIG_SUMO_SIM_anti_2 | 182 | 191 | PF11976 | 0.416 |
LIG_UBA3_1 | 192 | 201 | PF00899 | 0.367 |
MOD_CDC14_SPxK_1 | 74 | 77 | PF00782 | 0.563 |
MOD_CDK_SPxK_1 | 71 | 77 | PF00069 | 0.579 |
MOD_CK1_1 | 149 | 155 | PF00069 | 0.721 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.738 |
MOD_CK1_1 | 84 | 90 | PF00069 | 0.629 |
MOD_CK2_1 | 188 | 194 | PF00069 | 0.248 |
MOD_CK2_1 | 33 | 39 | PF00069 | 0.537 |
MOD_CK2_1 | 42 | 48 | PF00069 | 0.548 |
MOD_DYRK1A_RPxSP_1 | 157 | 161 | PF00069 | 0.553 |
MOD_GlcNHglycan | 132 | 135 | PF01048 | 0.618 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.738 |
MOD_GlcNHglycan | 239 | 243 | PF01048 | 0.340 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.649 |
MOD_GlcNHglycan | 85 | 89 | PF01048 | 0.714 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.752 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.675 |
MOD_GSK3_1 | 38 | 45 | PF00069 | 0.518 |
MOD_N-GLC_1 | 19 | 24 | PF02516 | 0.531 |
MOD_N-GLC_1 | 3 | 8 | PF02516 | 0.707 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.667 |
MOD_NEK2_1 | 31 | 36 | PF00069 | 0.740 |
MOD_NEK2_2 | 246 | 251 | PF00069 | 0.297 |
MOD_PKA_1 | 42 | 48 | PF00069 | 0.562 |
MOD_PKA_2 | 156 | 162 | PF00069 | 0.628 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.706 |
MOD_PKA_2 | 42 | 48 | PF00069 | 0.648 |
MOD_Plk_1 | 19 | 25 | PF00069 | 0.559 |
MOD_Plk_4 | 188 | 194 | PF00069 | 0.248 |
MOD_Plk_4 | 246 | 252 | PF00069 | 0.324 |
MOD_ProDKin_1 | 120 | 126 | PF00069 | 0.446 |
MOD_ProDKin_1 | 157 | 163 | PF00069 | 0.593 |
MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.579 |
MOD_SUMO_for_1 | 179 | 182 | PF00179 | 0.416 |
MOD_SUMO_rev_2 | 107 | 117 | PF00179 | 0.536 |
TRG_DiLeu_BaEn_1 | 183 | 188 | PF01217 | 0.416 |
TRG_ENDOCYTIC_2 | 176 | 179 | PF00928 | 0.351 |
TRG_ENDOCYTIC_2 | 227 | 230 | PF00928 | 0.487 |
TRG_ENDOCYTIC_2 | 245 | 248 | PF00928 | 0.205 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0P6W1 | Trypanosomatidae | 46% | 100% |
A0A3S7WUW6 | Leishmania donovani | 70% | 100% |
A4HXU8 | Leishmania infantum | 70% | 100% |
E9ARL0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 68% | 100% |
Q4QDW9 | Leishmania major | 70% | 97% |